Showing results (281-290 of 389) with videos related to

Sort By:
Pageof 39
Surgical Oncology|March 19, 2018
Association of preoperative serum CRP with PD-L1 expression in 508 patients with non-small cell lung cancer: A comprehensive analysis of systemic inflammatory markersTakaki Akamine, Kazuki Takada, Gouji Toyokawa, et al.
Lung Cancer (Amsterdam, Netherlands)|July 2, 2025
Durvalumab plus irinotecan + cisplatin for untreated extensive-stage small cell lung cancer: REBORN, phase II study (WJOG13520L)Motoko Tachihara, Hiroyasu Shoda, Yuki Akazawa, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 18, 2009
Combined survival analysis of prospective clinical trials of gefitinib for non-small cell lung cancer with EGFR mutationsSatoshi Morita, Isamu Okamoto, Kunihiko Kobayashi, et al.
Cancer Science|September 2, 2016
FGFR gene alterations in lung squamous cell carcinoma are potential targets for the multikinase inhibitor nintedanibMasaaki Hibi, Hiroyasu Kaneda, Junko Tanizaki, et al.
Scientific Reports|December 22, 2019
Heregulin expression and its clinical implication for patients with EGFR-mutant non-small cell lung cancer treated with EGFR-tyrosine kinase inhibitorsKimio Yonesaka, Eiji Iwama, Hidetoshi Hayashi, et al.
Anticancer Research|December 27, 2017
Clinical Significance of PD-L1 Expression in Brain Metastases from Non-small Cell Lung CancerShinkichi Takamori, Gouji Toyokawa, Isamu Okamoto, et al.
Anticancer Research|July 26, 2017
Discrepancy in Programmed Cell Death-Ligand 1 Between Primary and Metastatic Non-small Cell Lung CancerShinkichi Takamori, Gouji Toyokawa, Isamu Okamoto, et al.
Lung Cancer (Amsterdam, Netherlands)|November 16, 2018
Phase I/II study of carboplatin plus nab-paclitaxel and concurrent radiotherapy for patients with locally advanced non-small cell lung cancerYuko Kawano, Tomonari Sasaki, Hiroyuki Yamaguchi, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 28, 2009
Phase I study of YM155, a novel survivin suppressant, in patients with advanced solid tumorsTaroh Satoh, Isamu Okamoto, Masaki Miyazaki, et al.
Oncotarget|August 11, 2018
Detection of identical T cell clones in peritumoral pleural effusion and pneumonitis lesions in a cancer patient during immune-checkpoint blockadeKentaro Tanaka, Toyoshi Yanagihara, Yuki Ikematsu, et al.
Pageof 39